| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 08, 2026 |
Fate Therapeutics Inc
FATE
|
BUY |
$7.00
Est. +254%
|
$1.98 | $2.16 |
Pending
|
$2.01
+1.5%
|
| Feb 18, 2026 |
PepGen Inc
PEPG
|
BUY |
$7.00
Est. +3%
|
$6.79 | $7.05 |
Bullseye Hit (±1%)
|
$1.47
-78.4%
|
| Dec 04, 2025 |
Pharvaris NV
PHVS
|
BUY |
$39.00
Est. +33%
|
$29.37 | $33.29 |
Pending
|
$31.54
+7.4%
|
| Oct 17, 2025 |
Krystal Biotech Inc
KRYS
|
BUY |
$224.00
Est. +19%
|
$188.33 | $332.99 |
Target Met
|
$324.75
+72.4%
|
| Aug 13, 2025 |
Intellia Therapeutics Inc
NTLA
|
BUY |
$14.00
Est. +24%
|
$11.25 | $28.24 |
Target Met
|
$14.92
+32.6%
|
| May 07, 2025 |
Beam Therapeutics Inc
BEAM
|
BUY |
$55.00
Est. +244%
|
$15.99 | $36.44 |
Miss
|
$31.12
+94.6%
|
| Mar 28, 2025 |
Soleno Therapeutics Inc
SLNO
|
BUY |
$81.00
Est. +15%
|
$70.22 | $90.15 |
Target Met
|
$53.01
-24.5%
|
| Nov 15, 2024 |
Centessa Pharmaceuticals plc - ADR
CNTA
|
BUY |
$28.00
Est. +64%
|
$17.10 | $27.72 |
Bullseye Hit (±1%)
|
$39.76
+132.5%
|
| Oct 09, 2024 |
Ionis Pharmaceuticals Inc
IONS
|
BUY |
$65.00
Est. +72%
|
$37.80 | $71.87 |
Target Met
|
$73.96
+95.7%
|
| Sep 11, 2024 |
Stoke Therapeutics Inc
STOK
|
BUY |
$35.00
Est. +128%
|
$15.32 | $24.00 |
Miss
|
$30.00
+95.8%
|
| Aug 27, 2024 |
Rezolute Inc
RZLT
|
BUY |
$11.00
Est. +134%
|
$4.70 | $7.46 |
Miss
|
$4.33
-7.9%
|
| May 16, 2024 |
Fate Therapeutics Inc
FATE
|
BUY |
$5.00
Est. +18%
|
$4.24 | $5.91 |
Target Met
|
$2.01
-52.6%
|
| May 16, 2024 |
Allogene Therapeutics Inc
ALLO
|
BUY |
$9.00
Est. +202%
|
$2.98 | $3.78 |
Miss
|
$1.94
-34.9%
|
| May 14, 2024 |
Amicus Therapeutics Inc
FOLD
|
BUY |
$13.00
Est. +44%
|
$9.04 | $12.65 |
Precision Hit (±3%)
|
$14.49
+60.3%
|
| May 13, 2024 |
Macrogenics Inc
MGNX
|
SELL |
$4.00
Est. +9%
|
$4.38 | $1.00 (Low) |
Target Met
|
$4.13
+5.7%
|
| Feb 03, 2022 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$170.00
Est. +19%
|
$142.51 | - | - |
$287.80
+102.0%
|
| Dec 01, 2021 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$286.00
Est. +40%
|
$205.00 | - | - |
$450.69
+119.8%
|
| Nov 19, 2021 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$120.00
Est. +31%
|
$91.47 | - | - |
$55.65
-39.2%
|